JP6968168B2 - インジゴカルミンを調製する方法 - Google Patents
インジゴカルミンを調製する方法 Download PDFInfo
- Publication number
- JP6968168B2 JP6968168B2 JP2019528826A JP2019528826A JP6968168B2 JP 6968168 B2 JP6968168 B2 JP 6968168B2 JP 2019528826 A JP2019528826 A JP 2019528826A JP 2019528826 A JP2019528826 A JP 2019528826A JP 6968168 B2 JP6968168 B2 JP 6968168B2
- Authority
- JP
- Japan
- Prior art keywords
- indigo
- sulfonic acid
- disodium
- sulfonate
- leuco
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- KHLVKKOJDHCJMG-QDBORUFSSA-L indigo carmine Chemical compound [Na+].[Na+].N/1C2=CC=C(S([O-])(=O)=O)C=C2C(=O)C\1=C1/NC2=CC=C(S(=O)(=O)[O-])C=C2C1=O KHLVKKOJDHCJMG-QDBORUFSSA-L 0.000 title description 19
- 229960003988 indigo carmine Drugs 0.000 title description 18
- 235000012738 indigotine Nutrition 0.000 title description 18
- 239000004179 indigotine Substances 0.000 title description 18
- 229940097275 indigo Drugs 0.000 claims description 110
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims description 63
- 239000000203 mixture Substances 0.000 claims description 59
- 238000000034 method Methods 0.000 claims description 57
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 claims description 32
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 claims description 31
- 238000011282 treatment Methods 0.000 claims description 29
- 235000000177 Indigofera tinctoria Nutrition 0.000 claims description 22
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 claims description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000012429 reaction media Substances 0.000 claims description 18
- 239000007787 solid Substances 0.000 claims description 15
- 239000007800 oxidant agent Substances 0.000 claims description 13
- 238000004519 manufacturing process Methods 0.000 claims description 12
- 239000012535 impurity Substances 0.000 claims description 11
- 238000001914 filtration Methods 0.000 claims description 10
- 239000002609 medium Substances 0.000 claims description 10
- 235000013305 food Nutrition 0.000 claims description 9
- 230000001590 oxidative effect Effects 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 8
- 238000004128 high performance liquid chromatography Methods 0.000 claims description 7
- 238000000746 purification Methods 0.000 claims description 7
- JVBXVOWTABLYPX-UHFFFAOYSA-L sodium dithionite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])=O JVBXVOWTABLYPX-UHFFFAOYSA-L 0.000 claims description 7
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 6
- 239000012736 aqueous medium Substances 0.000 claims description 5
- 230000003647 oxidation Effects 0.000 claims description 5
- 238000007254 oxidation reaction Methods 0.000 claims description 5
- 230000001476 alcoholic effect Effects 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 4
- 239000012502 diagnostic product Substances 0.000 claims description 4
- 239000001301 oxygen Substances 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 239000000825 pharmaceutical preparation Substances 0.000 claims description 4
- 239000002244 precipitate Substances 0.000 claims description 4
- 239000007858 starting material Substances 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 3
- 238000011084 recovery Methods 0.000 claims description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 27
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 12
- 239000000047 product Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 238000006243 chemical reaction Methods 0.000 description 8
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 6
- -1 1,3-dihydro-3-oxo-2H-indole-2-ylidene Chemical group 0.000 description 5
- 239000003960 organic solvent Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 239000003814 drug Substances 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000356 contaminant Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- KBPLFHHGFOOTCA-UHFFFAOYSA-N 1-Octanol Chemical compound CCCCCCCCO KBPLFHHGFOOTCA-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003638 chemical reducing agent Substances 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 229940088679 drug related substance Drugs 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 239000012064 sodium phosphate buffer Substances 0.000 description 2
- UKUVVAMSXXBMRX-UHFFFAOYSA-N 2,4,5-trithia-1,3-diarsabicyclo[1.1.1]pentane Chemical compound S1[As]2S[As]1S2 UKUVVAMSXXBMRX-UHFFFAOYSA-N 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 241000392288 Tudora Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000008186 active pharmaceutical agent Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- JXLHNMVSKXFWAO-UHFFFAOYSA-N azane;7-fluoro-2,1,3-benzoxadiazole-4-sulfonic acid Chemical compound N.OS(=O)(=O)C1=CC=C(F)C2=NON=C12 JXLHNMVSKXFWAO-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229920002678 cellulose Chemical class 0.000 description 1
- 239000001913 cellulose Chemical class 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 239000013065 commercial product Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 125000001041 indolyl group Chemical group 0.000 description 1
- 239000013067 intermediate product Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 239000008363 phosphate buffer Chemical class 0.000 description 1
- 229920000642 polymer Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 230000019432 tissue death Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B67/00—Influencing the physical, e.g. the dyeing or printing properties of dyestuffs without chemical reactions, e.g. by treating with solvents grinding or grinding assistants, coating of pigments or dyes; Process features in the making of dyestuff preparations; Dyestuff preparations of a special physical nature, e.g. tablets, films
- C09B67/0096—Purification; Precipitation; Filtration
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B7/00—Indigoid dyes
- C09B7/08—Other indole-indigos
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L5/00—Preparation or treatment of foods or foodstuffs, in general; Food or foodstuffs obtained thereby; Materials therefor
- A23L5/40—Colouring or decolouring of foods
- A23L5/42—Addition of dyes or pigments, e.g. in combination with optical brighteners
- A23L5/47—Addition of dyes or pigments, e.g. in combination with optical brighteners using synthetic organic dyes or pigments not covered by groups A23L5/43 - A23L5/46
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B7/00—Indigoid dyes
- C09B7/02—Bis-indole indigos
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Paper (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Description
i)インジゴを、5,5′−インジゴスルホン酸を含有する混合物に導くスルホン化処理に供する工程を含み、この方法は、
ii)工程i)で得られた混合物を、ロイコ−5,5′−インジゴスルホン酸を含む組成物を得るために、還元処理および任意に精製工程に供することと、
iii)ロイコ−5,5′−インジゴスルホン酸が、工程ii)で得られた組成物から単離されることと、
iv)工程iii)で得られたロイコ−5,5′−インジゴスルホン酸を5,5′−インジゴスルホン酸二ナトリウムに酸化することと、
を特徴とする。
iiia)工程ii)で得られた組成物のろ過と、
iiib)フィルター上に残った固体の回収と、
からなる少なくとも1つの工程を含む。
工程i)インジゴのスルホン化
工程ii)工程i)で得られた混合物の還元
工程iii)ロイコ−5,5′−インジゴスルホン酸の分離
工程iv)ロイコ−5,5′−インジゴスルホン酸の酸化
用途
1.出発原料および機器
2.分析方法
機械:Agilent1100(登録商標)
カラム:KROMASIL C18(登録商標)150x4.6−5μm
検出:290nm
試料濃度:1000ppm
試料溶解用溶媒:90/10 H2O/MeOH
溶出溶媒:10mMリン酸ナトリウム緩衝液(pH3.0)+1mM TBACl/MeOH
II−プロトコル
1.5,5′−インジゴスルホン酸へのインジゴの変換
2.5,5′−インジゴスルホン酸を含む混合物の還元
3.ロイコ−5,5′−インジゴスルホン酸の分離
4.ロイコ−5,5′−インジゴスルホン酸の洗浄
5.ロイコ−5,5′−インジゴスルホン酸二ナトリウムの5,5′−インジゴスルホン酸二ナトリウムへの変換
6.5,5′−インジゴスルホン酸二ナトリウムの洗浄
III−結果
Claims (15)
- 出発原料をインジゴとする5,5′−インジゴスルホン酸二ナトリウムを調製する方法であって、この方法が、以下の
i)5,5′−インジゴスルホン酸を含有する混合物を得るスルホン化処理にインジゴを供する工程を含み、
この方法が、
ii)ロイコ−5,5′−インジゴスルホン酸を含む組成物を得るために、工程i)で得られた前記混合物を還元処理および任意に精製工程に供することと、
iii)前記ロイコ−5,5′−インジゴスルホン酸が、工程ii)で得られた前記組成物から単離されることと、
iv)工程iii)で得られた前記ロイコ−5,5′−インジゴスルホン酸を5,5′−インジゴスルホン酸二ナトリウムに酸化することと、
を特徴とする、方法。 - 工程ii)の前記還元処理が、水性媒体中で亜ジチオン酸ナトリウムを使用して実施される、請求項1に記載の方法。
- 前記ロイコ−5,5′−インジゴスルホン酸が、工程ii)の終了時に前記反応媒体中に沈殿する、請求項1または請求項2に記載の方法。
- 工程iii)が、
iiia)工程ii)で得られた前記組成物のろ過と、
iiib)フィルター上に残った固体の回収と、
からなる少なくとも1つの工程を含む、請求項1〜3のいずれか一項に記載の方法。 - 工程iii)が、工程iiib)後に、前記固体を水性媒体で洗浄することからなる少なくとも1つの工程iiic)も含む、請求項4に記載の方法。
- 工程iiic)が1〜5回適用される、請求項5に記載の方法。
- 工程iii)の終了時に得られる前記組成物が、前記組成物の合計モル数に対して少なくとも90モル%のロイコ−5,5′−インジゴスルホン酸を含む、請求項1〜6のいずれか一項に記載の方法。
- 工程iv)が、酸化剤の存在下でのアルコール媒体中での塩基での処理からなる少なくとも1つの工程iva)を含む、請求項1〜7のいずれか一項に記載の方法。
- 工程iva)が、酸化剤の存在下でのエタノール中でのナトリウムエトキシドでの処理からなる、請求項8に記載の方法。
- 前記酸化剤が気体酸素である、請求項8または請求項9に記載の方法。
- 工程iva)後に、1つ以上のアルコール性および/または水性−アルコール性溶媒での1回以上の洗浄からなる少なくとも1つの工程ivb)も含む、請求項8〜10のいずれか一項に記載の方法。
- 少なくとも99.5%の5,5′−インジゴスルホン酸二ナトリウムを含む組成物を生成するための、請求項1〜11のいずれか一項に記載の方法の使用であって、前記百分率が290nmで検出する高圧液体クロマトグラフィーによって測定される、使用。
- 不純物が0.10%を超える量で存在しない組成物を生成するための、請求項1〜11のいずれか一項に記載の方法の使用であって、前記百分率が290nmで検出する高圧液体クロマトグラフィーによって測定される、使用。
- 5,5′−インジゴスルホン酸二ナトリウムを含む医薬または診断用製品を製造する方法であって、請求項1〜11のいずれか一項に記載の方法による5,5′−インジゴスルホン酸二ナトリウムの製造および薬学的に許容される支持体への前記5,5′−インジゴスルホン酸二ナトリウムの導入を含む、方法。
- 5,5′−インジゴスルホン酸二ナトリウムを含む食品組成物を製造する方法であって、請求項1〜11のいずれか一項に記載の方法による5,5′−インジゴスルホン酸二ナトリウムの製造および食品用途に適合する支持体への前記5,5′−インジゴスルホン酸二ナトリウムの導入を含む、方法。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1661784 | 2016-12-01 | ||
FR1661784A FR3059664B1 (fr) | 2016-12-01 | 2016-12-01 | Procede de preparation du carmin d’indigo |
PCT/FR2017/053260 WO2018100277A1 (fr) | 2016-12-01 | 2017-11-27 | Procede de preparation du carmin d'indigo |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2020500973A JP2020500973A (ja) | 2020-01-16 |
JP6968168B2 true JP6968168B2 (ja) | 2021-11-17 |
Family
ID=58347529
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2019528826A Active JP6968168B2 (ja) | 2016-12-01 | 2017-11-27 | インジゴカルミンを調製する方法 |
Country Status (17)
Country | Link |
---|---|
US (2) | US10767054B2 (ja) |
EP (1) | EP3548563B1 (ja) |
JP (1) | JP6968168B2 (ja) |
KR (1) | KR102432094B1 (ja) |
CN (1) | CN110023414B (ja) |
AU (1) | AU2017369779B2 (ja) |
BR (1) | BR112019010919B1 (ja) |
CA (1) | CA3044447A1 (ja) |
ES (1) | ES2928385T3 (ja) |
FR (1) | FR3059664B1 (ja) |
IL (1) | IL266928B (ja) |
MA (1) | MA46994A (ja) |
MX (1) | MX2019006209A (ja) |
MY (1) | MY193062A (ja) |
RU (1) | RU2748041C2 (ja) |
WO (1) | WO2018100277A1 (ja) |
ZA (1) | ZA201903450B (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112824386A (zh) * | 2019-11-20 | 2021-05-21 | 哈工大机器人南昌智能制造研究院 | 马蓝鲜叶连续制备青黛、靛蓝、靛玉红的方法 |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE180097C (ja) * | ||||
US647280A (en) | 1899-12-07 | 1900-04-10 | John R Geigy & Co | Process of producing indigo. |
DE2742875A1 (de) * | 1977-09-23 | 1979-04-05 | Merck Patent Gmbh | Verfahren und mittel zur bestimmung von sauerstoff im blut |
RU1793717C (ru) * | 1990-05-21 | 1996-01-10 | Всесоюзный научно-исследовательский институт пищевых ароматизаторов, кислот и красителей | Способ получения красителя индигокармин |
WO2010018723A1 (ja) | 2008-08-12 | 2010-02-18 | マイラン製薬株式会社 | 液状インジゴカルミン製剤 |
JP5615821B2 (ja) * | 2009-08-05 | 2014-10-29 | ナガセ医薬品株式会社 | インジゴカルミン製剤 |
WO2011026109A1 (en) | 2009-08-31 | 2011-03-03 | Uwm Research Foundation, Inc. | Pigments and methods of making pigments |
IT1398643B1 (it) | 2010-03-04 | 2013-03-08 | Cosmo Technologies Ltd | Composizione solida per la somministrazione orale di coloranti, e utilizzo diagnostico della stessa |
JP5732283B2 (ja) | 2011-03-10 | 2015-06-10 | 癸巳化成株式会社 | 6,6’‐ジブロモインジゴの製造方法 |
WO2014001050A1 (en) * | 2012-06-26 | 2014-01-03 | Unilever Plc | Colloidal particles comprising hydrophobic polymer, curcuminoid, and blue colourant |
US20140155625A1 (en) * | 2012-11-30 | 2014-06-05 | Xerox Corporation | Modified Naturally-Derived Colorants For Phase Change Ink Applications |
KR102344079B1 (ko) * | 2014-01-29 | 2021-12-29 | 코스모 테크놀러지스 리미티드 | 하나 이상의 염료를 함유하는 직장 투여용 에멀젼 또는 마이크로에멀젼 형태의 액체 조성물, 및 s상 결장 및/또는 직장의 내시경 진단 절차에서의 이의 용도 |
US10124074B2 (en) * | 2014-02-26 | 2018-11-13 | Toufic Kachaamy | Indirect chromoendoscopy with an oral indigo carmine base preparation |
US10927258B2 (en) | 2016-12-23 | 2021-02-23 | Biophore India Pharmaceuticals Pvt. Ltd. | Process for the preparation of Indigotindisulfonate sodium (indigo carmine) |
-
2016
- 2016-12-01 FR FR1661784A patent/FR3059664B1/fr active Active
-
2017
- 2017-11-27 CN CN201780074084.5A patent/CN110023414B/zh active Active
- 2017-11-27 BR BR112019010919-6A patent/BR112019010919B1/pt active IP Right Grant
- 2017-11-27 MA MA046994A patent/MA46994A/fr unknown
- 2017-11-27 MX MX2019006209A patent/MX2019006209A/es unknown
- 2017-11-27 EP EP17811661.2A patent/EP3548563B1/fr active Active
- 2017-11-27 AU AU2017369779A patent/AU2017369779B2/en active Active
- 2017-11-27 KR KR1020197016157A patent/KR102432094B1/ko active IP Right Grant
- 2017-11-27 RU RU2019115440A patent/RU2748041C2/ru active
- 2017-11-27 WO PCT/FR2017/053260 patent/WO2018100277A1/fr active Application Filing
- 2017-11-27 JP JP2019528826A patent/JP6968168B2/ja active Active
- 2017-11-27 ES ES17811661T patent/ES2928385T3/es active Active
- 2017-11-27 CA CA3044447A patent/CA3044447A1/fr active Pending
- 2017-11-27 MY MYPI2019002853A patent/MY193062A/en unknown
- 2017-11-27 US US16/465,040 patent/US10767054B2/en active Active
-
2019
- 2019-05-28 IL IL266928A patent/IL266928B/en active IP Right Grant
- 2019-05-30 ZA ZA2019/03450A patent/ZA201903450B/en unknown
-
2020
- 2020-05-27 US US16/884,107 patent/US20200283632A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
ES2928385T3 (es) | 2022-11-17 |
FR3059664B1 (fr) | 2019-01-25 |
KR102432094B1 (ko) | 2022-08-12 |
AU2017369779B2 (en) | 2020-01-02 |
RU2019115440A3 (ja) | 2021-01-11 |
WO2018100277A1 (fr) | 2018-06-07 |
EP3548563A1 (fr) | 2019-10-09 |
US20190292370A1 (en) | 2019-09-26 |
KR20190088486A (ko) | 2019-07-26 |
BR112019010919A2 (pt) | 2019-10-08 |
ZA201903450B (en) | 2020-08-26 |
JP2020500973A (ja) | 2020-01-16 |
AU2017369779A1 (en) | 2019-06-06 |
EP3548563B1 (fr) | 2022-08-10 |
MA46994A (fr) | 2019-10-09 |
RU2748041C2 (ru) | 2021-05-19 |
RU2019115440A (ru) | 2021-01-11 |
FR3059664A1 (fr) | 2018-06-08 |
CN110023414B (zh) | 2021-03-19 |
IL266928A (en) | 2019-07-31 |
IL266928B (en) | 2020-11-30 |
CN110023414A (zh) | 2019-07-16 |
MY193062A (en) | 2022-09-26 |
CA3044447A1 (fr) | 2018-06-07 |
US20200283632A1 (en) | 2020-09-10 |
MX2019006209A (es) | 2019-09-26 |
US10767054B2 (en) | 2020-09-08 |
BR112019010919B1 (pt) | 2023-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2616453C (fr) | Nouveaux derives de polyquinoleines et leur utilisation therapeutique | |
CN111196819B (zh) | 一类d-a-d型苯并吡嗪类化合物及制备方法和应用 | |
CN113603654B (zh) | 一种检测脂滴和/或蛋白质聚集体的双功能荧光探针及其制备方法和用途 | |
JP6968168B2 (ja) | インジゴカルミンを調製する方法 | |
CN115485282A (zh) | 一种氧氮杂螺环化合物、其盐型及其晶型 | |
EP3982974A1 (en) | Novel improved method for synthesizing diaminophenothiazine compounds | |
CN105263899B (zh) | 苯氧基烷基胺化合物 | |
JP5671040B2 (ja) | 4,5,6,7−テトラクロロ−3’,6’−ジヒドロキシ−2’,4’,5’,7’−テトラヨード−3h−スピロ[イソベンゾフラン−1,9’−キサンテン]−3−オン(ローズベンガル)及び関連するキサンテンを合成するプロセス | |
EP1664044B1 (fr) | Sel de sodium monohydrate du s-tenatoprazole et application en tant qu'inhibiteur de la pompe a protons | |
FI69453B (fi) | Saett att framstaella en ny polymorf form av terapeutiskt anvaendbar 2-(4-klorfenyl)-alfa-metyl-5-bensoxazolylaettiksyra | |
CN106336411B (zh) | Cdk4/6抑制剂帕博西尼高纯度原料药的制备工艺及用途 | |
CN104530112A (zh) | 依维莫司中间体及其乙基化杂质的制备方法 | |
CN108484523A (zh) | 苯并氧杂恶二唑衍生物及其制备方法和应用 | |
CN106565615A (zh) | 一种磺胺多辛衍生物的制备方法 | |
CN104402815A (zh) | 磷酸哌喹杂质的控制方法 | |
CN114213502B (zh) | 一种非那雄胺的精制方法及非那雄胺制剂和其制备方法 | |
CN106831853A (zh) | 7‑乙基‑10‑o‑叔丁基二苯基硅基喜树碱‑20‑o‑甘氨酸盐酸盐的制备工艺 | |
CN108929269A (zh) | 苄异喹啉类非去极化肌松剂及其制备方法和用途 | |
CN106432077A (zh) | 匹杉琼马来酸盐的制备方法 | |
CN115745913A (zh) | 曲法罗汀多晶型及其制备方法 | |
JP2022074008A (ja) | トレプロスチニル一水和物結晶およびその製造方法 | |
STAN et al. | INFLUENCE OF EXTRACTION SOLVENT ON THE ERYTHROMYCIN ETHYLSUCCINATE SEPARATION FROM ORAL SUSPENDABLE POWDER | |
CN108117561A (zh) | 一种甲磺酸胺银杏内酯b代谢产物及合成和纯化方法 | |
JPS5953486A (ja) | 3−デアザグアニンスルホン酸塩 | |
ITMI992406A1 (it) | Complessi di paroxetina base con ciclodestrine o derivati delle ciclodestrine |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20200908 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20210816 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20211005 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20211026 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6968168 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |